After failing to convince the government to look into possibly raising prices again, the Federation of Egyptian Industries (FEI) pharma division is taking its case to the House of Representatives, sources tell Al Borsa. The division plans to send a memo to the House beseeching them on the “tough time the pharma sector is going through” as a result of prices staying the same since January. Yet their pleas seem likely to fall on deaf ears, according to statements from House Health Committee member Samy Al Mashd. Driven mostly by foreign pharma companies, the FEI still plans to push the issue with the Ismail cabinet and are awaiting the return of Prime Minister Sherif Ismail from Germany to intensify lobbying efforts. After repeated snubs by the Health Ministry, the lobby group will apparently focus its efforts with the Trade and Industry Ministry and the Investment Ministry.
More from Enterprise
Banks threaten to look beyond London as windfall tax talk grows
International lenders say more tax could tip the balance as…
Granite is about to test whether Egypt’s funds still need administrators
The asset manager and blockchain builder Tarmiiz have entered the…
Gulf stock exchanges are growing in importance, but they’re still a long way from becoming capital market hubs -Fitch
The diagnosis lands in a year when UAE and Saudi…
Egyptian-UK fintech Zeal raises USD 10 mn to back expansion plans
The London-based, Egyptian-founded fintech is preparing to activate its loyalty…